The Pan-Mass Challenge (PMC), renowned as the world’s most successful athletic fundraiser, has achieved a monumental milestone by surpassing $1 billion in lifetime fundraising for cancer research and treatment. This remarkable achievement comes as the PMC celebrates its 45th annual ride, bringing together thousands of cyclists and volunteers from around the globe.
Founded in 1980, the PMC has grown exponentially, now contributing 62% of the Jimmy Fund’s annual revenue for the Dana-Farber Cancer Institute. This year’s event aims to raise an unprecedented $75 million, with 6,800 riders participating in routes ranging from 25 to 211 miles across Massachusetts.
The funds raised by the PMC have been instrumental in driving significant advancements in cancer research and treatment. Notably, PMC funding has supported innovative programs at Dana-Farber, including the development of tovorafenib (OJEMDA), a drug targeting pediatric low-grade glioma. This breakthrough was made possible through early clinical trials funded by PMC riders.
Billy Starr, the founder and executive director of the PMC, expressed his gratitude for the community’s unwavering support. “While I knew in 1980 that I had created something special, I couldn’t have predicted the PMC would turn into the fundraising behemoth it is today,” Starr said. “As I saddle up for my 45th ride, I am immensely grateful for each and every individual who has contributed to this $1 billion fundraising achievement and who will help us kick start fundraising towards our next billion.”
The PMC continues to make a profound impact on cancer research, with 100% of every rider-raised dollar going directly to Dana-Farber. This commitment has enabled the institute to pioneer new treatments and improve standards of care, ultimately saving lives and advancing the fight against cancer.
For more information about the Pan-Mass Challenge and how to get involved, visit their official website.